NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|1002298665|ref|XP_015612758|]
View 

lanC-like protein GCL2 isoform X1 [Oryza sativa Japonica Group]

Protein Classification

euk_LANCL domain-containing protein( domain architecture ID 10524114)

euk_LANCL domain-containing protein

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
LANC_like pfam05147
Lanthionine synthetase C-like protein; Lanthionines are thioether bridges that are putatively ...
106-448 2.36e-127

Lanthionine synthetase C-like protein; Lanthionines are thioether bridges that are putatively generated by dehydration of Ser and Thr residues followed by addition of cysteine residues within the peptide. This family contains the lanthionine synthetase C-like proteins 1 and 2 which are related to the bacterial lanthionine synthetase components C (LanC). LANCL1 (P40 seven-transmembrane-domain protein) and LANCL2 (testes-specific adriamycin sensitivity protein) are thought to be peptide-modifying enzyme components in eukaryotic cells. Both proteins are produced in large quantities in the brain and testes and may have role in the immune surveillance of these organs. Lanthionines are found in lantibiotics, which are peptide-derived, post-translationally modified antimicrobials produced by several bacterial strains. This region contains seven internal repeats.


:

Pssm-ID: 398697 [Multi-domain]  Cd Length: 350  Bit Score: 372.48  E-value: 2.36e-127
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 106 VTDYTLYTGALGTALLLFKSFQVTGNRADLALAGDIVKECDAASRGLPRRFLTFICGRAGVCALGAVIAKHCNDQLLLTH 185
Cdd:pfam05147   2 PLDDSLYTGLAGIALFLLELYKVTGNEKYLKLAHKYLEKIARALSEKGLPDISFFCGAAGIAYALAVASKLLGDYQLLLN 81
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 186 YLSSFDEIIVTEKVP---NELLYGRAGYLWACLFLNTHLGektIPHEHITSVAKDIIDEG-RKLAKKGNCPLMYEWHGKK 261
Cdd:pfam05147  82 YLDSALELIESNKLPdekYDLISGRAGILSYLLLLNEEFG---IEEDYLKLILKYLLRLGiRSENQFSWCPLMYEPYGNF 158
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 262 YWGAAHGLAGIMHVLMHTELKL---DEKDDVKNTLLYMIRNRYPT-GNYPSSEGSESDRLVHWCHGAPGVALTLAKAYQV 337
Cdd:pfam05147 159 NLGFAHGLSGIAYALLALYKGTkseKLLELIKKALNYEKSLKFKSeGNWPDSRGDKNDYLVAWCHGAPGILLALLLAYKA 238
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 338 FHDEHFKQTAAEAAEVVWNRG-LLKRVGICHGVSGNAYVFLSLYRLTGNVEYLYRAKAFACFLLEKADQLIADGAMHGGD 416
Cdd:pfam05147 239 LNDEEFLEEAIEALEVVWKRGlLLKNPSLCHGLSGNLYILLLLYRLTNDPKYLERAKKFIISLLDYGKKNGFKCGLPRGD 318
                         330       340       350
                  ....*....|....*....|....*....|..
gi 1002298665 417 HPFSLFEGRAGMAYLLLDMVSPSESKFPAYEL 448
Cdd:pfam05147 319 ESFGLMEGIAGIAYFLLDLLNPDESLFPSALL 350
 
Name Accession Description Interval E-value
LANC_like pfam05147
Lanthionine synthetase C-like protein; Lanthionines are thioether bridges that are putatively ...
106-448 2.36e-127

Lanthionine synthetase C-like protein; Lanthionines are thioether bridges that are putatively generated by dehydration of Ser and Thr residues followed by addition of cysteine residues within the peptide. This family contains the lanthionine synthetase C-like proteins 1 and 2 which are related to the bacterial lanthionine synthetase components C (LanC). LANCL1 (P40 seven-transmembrane-domain protein) and LANCL2 (testes-specific adriamycin sensitivity protein) are thought to be peptide-modifying enzyme components in eukaryotic cells. Both proteins are produced in large quantities in the brain and testes and may have role in the immune surveillance of these organs. Lanthionines are found in lantibiotics, which are peptide-derived, post-translationally modified antimicrobials produced by several bacterial strains. This region contains seven internal repeats.


Pssm-ID: 398697 [Multi-domain]  Cd Length: 350  Bit Score: 372.48  E-value: 2.36e-127
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 106 VTDYTLYTGALGTALLLFKSFQVTGNRADLALAGDIVKECDAASRGLPRRFLTFICGRAGVCALGAVIAKHCNDQLLLTH 185
Cdd:pfam05147   2 PLDDSLYTGLAGIALFLLELYKVTGNEKYLKLAHKYLEKIARALSEKGLPDISFFCGAAGIAYALAVASKLLGDYQLLLN 81
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 186 YLSSFDEIIVTEKVP---NELLYGRAGYLWACLFLNTHLGektIPHEHITSVAKDIIDEG-RKLAKKGNCPLMYEWHGKK 261
Cdd:pfam05147  82 YLDSALELIESNKLPdekYDLISGRAGILSYLLLLNEEFG---IEEDYLKLILKYLLRLGiRSENQFSWCPLMYEPYGNF 158
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 262 YWGAAHGLAGIMHVLMHTELKL---DEKDDVKNTLLYMIRNRYPT-GNYPSSEGSESDRLVHWCHGAPGVALTLAKAYQV 337
Cdd:pfam05147 159 NLGFAHGLSGIAYALLALYKGTkseKLLELIKKALNYEKSLKFKSeGNWPDSRGDKNDYLVAWCHGAPGILLALLLAYKA 238
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 338 FHDEHFKQTAAEAAEVVWNRG-LLKRVGICHGVSGNAYVFLSLYRLTGNVEYLYRAKAFACFLLEKADQLIADGAMHGGD 416
Cdd:pfam05147 239 LNDEEFLEEAIEALEVVWKRGlLLKNPSLCHGLSGNLYILLLLYRLTNDPKYLERAKKFIISLLDYGKKNGFKCGLPRGD 318
                         330       340       350
                  ....*....|....*....|....*....|..
gi 1002298665 417 HPFSLFEGRAGMAYLLLDMVSPSESKFPAYEL 448
Cdd:pfam05147 319 ESFGLMEGIAGIAYFLLDLLNPDESLFPSALL 350
euk_LANCL cd04794
Eukaryotic Lanthionine synthetase C-like protein; This family contains the lanthionine ...
111-444 8.61e-125

Eukaryotic Lanthionine synthetase C-like protein; This family contains the lanthionine synthetase C-like proteins 1 and 2 which are related to the bacterial lanthionine synthetase components C (LanC). LANCL1 and LANCL2 (testes-specific adriamycin sensitivity protein) were thought to be peptide-modifying enzyme components in eukaryotic cells. Both proteins are produced in large quantities in the brain and testes and may have role in the immune surveillance of these organs. More recently, they have been associated with signal transduction processes and insulin sensitization. In particular, LANCL2 has been shown to bind abscisic acid (ABA), and this interaction may play a role in signaling pathways triggered by ABA, such as in human granulocytes and rat insulinoma cells. This eukaryotic LANCL family also includes Arabidopsis GCR2.


Pssm-ID: 271202  Cd Length: 349  Bit Score: 366.27  E-value: 8.61e-125
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 111 LYTGALGTALLLFKSFQVTGNRAD-----LALAGDIVKECDAASRGLPRRFLTFICGRAGVCALGAVIAKHCNDQLLLTH 185
Cdd:cd04794     1 LYTGAAGIAYMFLRLSEQGPDLKAlsedyLELALEYIEASLTELARKGSSRISFLCGDAGILALAAVIYHALGDSERDEE 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 186 YLSSFDEIIVTEKV----PNELLYGRAGYLWACLFLNTHLGE-KTIPHEHITSVAKDIIDEGRKLAKKGN--CPLMYEWH 258
Cdd:cd04794    81 FLEQLLELAKEALPlddgPDELLYGRAGYLYALLFLRKHLGEsLEISDAVIKKLVDAILESGRQGAKDYRspPPLMYEWH 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 259 GKKYWGAAHGLAGIMHVLMHTELKLDEKD---DVKNTLLYMIRNRYPTGNYPSSEGSE--SDRLVHWCHGAPGVALTLAK 333
Cdd:cd04794   161 GKEYLGAAHGLAGILYMLLQAPPLLQIPSlapLIKETLDYLLSLQFPSGNWPSSLGERsrSDRLVQWCHGAPGVVYLLAK 240
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 334 AYQVFHDEHFKQTAAEAAEVVWNRGLLKR-VGICHGVSGNAYVFLSLYRLTGNVEYLYRAKAFACFLLEKADQLiadgAM 412
Cdd:cd04794   241 AYKVFLDPKYLEAAIRAGELVWERGLLRKgPGLCHGIAGNAYAFLLLYRLTGDEKYLYRALKFAEFALDYGFLT----GA 316
                         330       340       350
                  ....*....|....*....|....*....|...
gi 1002298665 413 HGGDHPFSLFEGRAGMAYLLLDM-VSPSESKFP 444
Cdd:cd04794   317 RTPDRPYSLFEGLAGTACFLADLlQGPRKARFP 349
LcnDR2 COG4403
Lantibiotic modifying enzyme [Defense mechanisms];
99-439 6.58e-29

Lantibiotic modifying enzyme [Defense mechanisms];


Pssm-ID: 443528 [Multi-domain]  Cd Length: 405  Bit Score: 117.15  E-value: 6.58e-29
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665  99 WTRARRQVTDYTLYTGALGTALLLFKSFQVTGNRADLALAGDIVKEC--DAASRGLPRRFLTFICGRAGVCALGAVIAKH 176
Cdd:COG4403    51 TRAAAAGPAAADLYDGAAGIALFLAELARLTGDERYRELARAALRPLrrLLREELAGAMGPGLFTGLGGIAYALAHLGEL 130
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 177 CNDQLLLTH---YLSSFDEIIVTEKvPNELLYGRAGYLWACLFLNTHLGEktiphEHITSVAKDIID---EGRKLAKKGN 250
Cdd:COG4403   131 LGDPRLLEDalaLAALLEELIAADE-SLDVISGAAGAILALLALYRATGD-----PAALDLAIRCGDrllAAAVRDDGGR 204
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 251 CPLMYEWHGKKYWGAAHGLAGIMHVLMHTELKLDEK---DDVKNTLLYMIRNRYP-TGNYP--SSEGSESDRLVHWCHGA 324
Cdd:COG4403   205 AWPTPEPAGRPLTGFAHGAAGIAYALLRLAAATGDErylEAAREALAYERSLFDPeGGNWPdlREPDDGPRFRTAWCHGA 284
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 325 PGVALTLAKAYQVFHDEHFKQTAAEAAEVVWNRGLLKRVGICHGVSGNAYVFLSLYRLTGNVEYLYRAKAFACFLLEKAD 404
Cdd:COG4403   285 AGIGLARLALLRALGDPELREDLERALETTLRRGFGRNDSLCHGDAGNLELLLRAARATGDPELLEAARRLAALLLARAE 364
                         330       340       350
                  ....*....|....*....|....*....|....*...
gi 1002298665 405 Q---LIADGAMHGGDHPfSLFEGRAGMAYLLLDMVSPS 439
Cdd:COG4403   365 RagpLGLPGLPRGVESP-GLMTGLAGIGYGLLRLAAPE 401
lanti_2_LanM TIGR03897
type 2 lantibiotic biosynthesis protein LanM; Members of this family are known generally as ...
83-433 1.71e-20

type 2 lantibiotic biosynthesis protein LanM; Members of this family are known generally as LanM, a multifunctional enzyme of lantibiotic biosynthesis. This catalysis by LanM distinguishes the type 2 lantibiotics, such as mersacidin, cinnamycin, and lichenicidin, from LanBC-produced type 1 lantibiotics such as nisin and subtilin. The N-terminal domain contains regions associated with Ser and Thr dehydration. The C-terminal region contains a pfam05147 domain, which catalyzes the formation of the lanthionine bridge. [Cellular processes, Toxin production and resistance]


Pssm-ID: 274840 [Multi-domain]  Cd Length: 931  Bit Score: 94.63  E-value: 1.71e-20
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665  83 LLRAALRIKDKVMEE---------TW---------TRARRQVTDYTLYTGALGTALLLFKSFQVTGNR--ADLALAGD-- 140
Cdd:TIGR03897 548 LLEEAKKIADRLLDNaiegddgsvNWiglnlsfdeERWSLGPLGNDLYDGLAGIALFLAYLAALTGDKryRDLARKALqp 627
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 141 IVKECDAASRGLPRRFLTFICGRAG-VCALgAVIAKHCNDQLLLTH---YLSSFDEIIVTEKVPNELLYGRAGYLWACLf 216
Cdd:TIGR03897 628 LRKYLETLVELARSMGLGAFSGLGSiIYAL-AHLGQLLNDPELLNDakkILNRLEELIIKDEEFLDLIGGAAGAILVLL- 705
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 217 lntHLGEKTiPHEHITSVAKDIideGRKLAKK-----GNCPLMYEWHGKKYWGAAHGLAGIMHVLmhteLKLDE------ 285
Cdd:TIGR03897 706 ---NLYEVT-GDPEVLELAIAC---GEHLLKQaveqeGGAAWKTSQSNKPLTGFSHGAAGIAWAL----LRLYKvtgdqr 774
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 286 -KDDVKNTLLYMiRNRYPT--GNYPSS-EGSESDRLVHWCHGAPGVALTLAKAYQVFHDEHFKQTAAEAAEVVWNRGLLK 361
Cdd:TIGR03897 775 yLEAAKEALAYE-RSLFDPeeGNWPDLrEDGGPQFPVAWCHGAPGILLSRLGLLEILDDDEIREDIEIALETTLKYGFGD 853
                         330       340       350       360       370       380       390
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1002298665 362 RVGICHGVSGNAYVFLSLYRLTGNVEYLYRAKAFACFLLEKADQ------LIADGAMHggdhpFSLFEGRAGMAYLLL 433
Cdd:TIGR03897 854 NDSLCHGDLGNLEILLEAAKVLDDEELQELARRIASQVLARLTKngryrlGLPRGVES-----PGLMTGLAGIGYGLL 926
 
Name Accession Description Interval E-value
LANC_like pfam05147
Lanthionine synthetase C-like protein; Lanthionines are thioether bridges that are putatively ...
106-448 2.36e-127

Lanthionine synthetase C-like protein; Lanthionines are thioether bridges that are putatively generated by dehydration of Ser and Thr residues followed by addition of cysteine residues within the peptide. This family contains the lanthionine synthetase C-like proteins 1 and 2 which are related to the bacterial lanthionine synthetase components C (LanC). LANCL1 (P40 seven-transmembrane-domain protein) and LANCL2 (testes-specific adriamycin sensitivity protein) are thought to be peptide-modifying enzyme components in eukaryotic cells. Both proteins are produced in large quantities in the brain and testes and may have role in the immune surveillance of these organs. Lanthionines are found in lantibiotics, which are peptide-derived, post-translationally modified antimicrobials produced by several bacterial strains. This region contains seven internal repeats.


Pssm-ID: 398697 [Multi-domain]  Cd Length: 350  Bit Score: 372.48  E-value: 2.36e-127
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 106 VTDYTLYTGALGTALLLFKSFQVTGNRADLALAGDIVKECDAASRGLPRRFLTFICGRAGVCALGAVIAKHCNDQLLLTH 185
Cdd:pfam05147   2 PLDDSLYTGLAGIALFLLELYKVTGNEKYLKLAHKYLEKIARALSEKGLPDISFFCGAAGIAYALAVASKLLGDYQLLLN 81
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 186 YLSSFDEIIVTEKVP---NELLYGRAGYLWACLFLNTHLGektIPHEHITSVAKDIIDEG-RKLAKKGNCPLMYEWHGKK 261
Cdd:pfam05147  82 YLDSALELIESNKLPdekYDLISGRAGILSYLLLLNEEFG---IEEDYLKLILKYLLRLGiRSENQFSWCPLMYEPYGNF 158
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 262 YWGAAHGLAGIMHVLMHTELKL---DEKDDVKNTLLYMIRNRYPT-GNYPSSEGSESDRLVHWCHGAPGVALTLAKAYQV 337
Cdd:pfam05147 159 NLGFAHGLSGIAYALLALYKGTkseKLLELIKKALNYEKSLKFKSeGNWPDSRGDKNDYLVAWCHGAPGILLALLLAYKA 238
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 338 FHDEHFKQTAAEAAEVVWNRG-LLKRVGICHGVSGNAYVFLSLYRLTGNVEYLYRAKAFACFLLEKADQLIADGAMHGGD 416
Cdd:pfam05147 239 LNDEEFLEEAIEALEVVWKRGlLLKNPSLCHGLSGNLYILLLLYRLTNDPKYLERAKKFIISLLDYGKKNGFKCGLPRGD 318
                         330       340       350
                  ....*....|....*....|....*....|..
gi 1002298665 417 HPFSLFEGRAGMAYLLLDMVSPSESKFPAYEL 448
Cdd:pfam05147 319 ESFGLMEGIAGIAYFLLDLLNPDESLFPSALL 350
euk_LANCL cd04794
Eukaryotic Lanthionine synthetase C-like protein; This family contains the lanthionine ...
111-444 8.61e-125

Eukaryotic Lanthionine synthetase C-like protein; This family contains the lanthionine synthetase C-like proteins 1 and 2 which are related to the bacterial lanthionine synthetase components C (LanC). LANCL1 and LANCL2 (testes-specific adriamycin sensitivity protein) were thought to be peptide-modifying enzyme components in eukaryotic cells. Both proteins are produced in large quantities in the brain and testes and may have role in the immune surveillance of these organs. More recently, they have been associated with signal transduction processes and insulin sensitization. In particular, LANCL2 has been shown to bind abscisic acid (ABA), and this interaction may play a role in signaling pathways triggered by ABA, such as in human granulocytes and rat insulinoma cells. This eukaryotic LANCL family also includes Arabidopsis GCR2.


Pssm-ID: 271202  Cd Length: 349  Bit Score: 366.27  E-value: 8.61e-125
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 111 LYTGALGTALLLFKSFQVTGNRAD-----LALAGDIVKECDAASRGLPRRFLTFICGRAGVCALGAVIAKHCNDQLLLTH 185
Cdd:cd04794     1 LYTGAAGIAYMFLRLSEQGPDLKAlsedyLELALEYIEASLTELARKGSSRISFLCGDAGILALAAVIYHALGDSERDEE 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 186 YLSSFDEIIVTEKV----PNELLYGRAGYLWACLFLNTHLGE-KTIPHEHITSVAKDIIDEGRKLAKKGN--CPLMYEWH 258
Cdd:cd04794    81 FLEQLLELAKEALPlddgPDELLYGRAGYLYALLFLRKHLGEsLEISDAVIKKLVDAILESGRQGAKDYRspPPLMYEWH 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 259 GKKYWGAAHGLAGIMHVLMHTELKLDEKD---DVKNTLLYMIRNRYPTGNYPSSEGSE--SDRLVHWCHGAPGVALTLAK 333
Cdd:cd04794   161 GKEYLGAAHGLAGILYMLLQAPPLLQIPSlapLIKETLDYLLSLQFPSGNWPSSLGERsrSDRLVQWCHGAPGVVYLLAK 240
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 334 AYQVFHDEHFKQTAAEAAEVVWNRGLLKR-VGICHGVSGNAYVFLSLYRLTGNVEYLYRAKAFACFLLEKADQLiadgAM 412
Cdd:cd04794   241 AYKVFLDPKYLEAAIRAGELVWERGLLRKgPGLCHGIAGNAYAFLLLYRLTGDEKYLYRALKFAEFALDYGFLT----GA 316
                         330       340       350
                  ....*....|....*....|....*....|...
gi 1002298665 413 HGGDHPFSLFEGRAGMAYLLLDM-VSPSESKFP 444
Cdd:cd04794   317 RTPDRPYSLFEGLAGTACFLADLlQGPRKARFP 349
LanC_like cd04434
Cyclases involved in the biosynthesis of lantibiotics, and similar proteins; LanC is the ...
112-445 5.08e-54

Cyclases involved in the biosynthesis of lantibiotics, and similar proteins; LanC is the cyclase enzyme of the lanthionine synthetase. Lanthionine is a lantibiotic, a unique class of peptide antibiotics. They are ribosomally synthesized as a precursor peptide and then post-translationally modified to contain thioether cross-links called lanthionines (Lans) or methyllanthionines (MeLans), in addition to 2,3-didehydroalanine (Dha) and (Z)-2,3-didehydrobutyrine (Dhb). These unusual amino acids are introduced by the dehydration of serine and threonine residues, followed by thioether formation via addition of cysteine thiols, catalysed by LanB and LanC or LanM. LanC, the cyclase component, is a zinc metalloprotein, whose bound metal has been proposed to activate the thiol substrate for nucleophilic addition. A related domain is also present in LanM and other pro- and eukaryotic proteins with poorly characterized functions.


Pssm-ID: 271198 [Multi-domain]  Cd Length: 351  Bit Score: 183.86  E-value: 5.08e-54
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 112 YTGALGTALLLFKSFQVTGNRADLALAGDIVKECDAASRGLPRRF--LTFICGRAGVCALGAVIAKHCNDQLLLTHYLSS 189
Cdd:cd04434     1 YHGAAGIALFLLELYRATGDKEYLDEAKEGADYLLARLEGLGEPLsgASLYSGLSGLLWALLELYEDLGDEKLLDALLDL 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 190 FDEIIVTEKV----PNELLYGRAGYLWACLFLNTHLGEKTIpHEHITSVAKDIIDEGRKLAKKGNCplmYEWHGKKYWGA 265
Cdd:cd04434    81 LDDIALEAKEvwwsGNDLILGDAGIILYLLYAAEKTGDEKY-KELAAKIGDFLLQAAEELDNGGNW---GLPKGSIYPGF 156
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 266 AHGLAGIMHVLMHTELKLDEK---DDVKNTLLYMIRNRYPTGNYPS--SEGSESDRLVHWCHGAPGVALTLAKAYQV--- 337
Cdd:cd04434   157 AHGTAGIAYALARLYEETGDEdflDAAKEGAEYLEAIAVGDEDGFLipLPDEKDLFYLGWCHGPAGTALLFYELYKAtgd 236
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 338 --FHDEHFKQTAAEAAEVVWNRGLLKRVGICHGVSGNAYVFLSLYRLTGN-----VEYLYRAKAFACFLLEKADQLIADG 410
Cdd:cd04434   237 ldLADELLEGIIKTGAPEKLSPGFWNNLCLCHGTAGVLEHLLYVYRLTGDereyaKRLADKLLGRATRNGEGLRWYQAWT 316
                         330       340       350
                  ....*....|....*....|....*....|....*
gi 1002298665 411 AMHGGDHPFSLFEGRAGMAYLLLDMVSPSESKFPA 445
Cdd:cd04434   317 GPGRVDASLGLMVGAAGIASALLKLLRAETKARPL 351
LcnDR2 COG4403
Lantibiotic modifying enzyme [Defense mechanisms];
99-439 6.58e-29

Lantibiotic modifying enzyme [Defense mechanisms];


Pssm-ID: 443528 [Multi-domain]  Cd Length: 405  Bit Score: 117.15  E-value: 6.58e-29
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665  99 WTRARRQVTDYTLYTGALGTALLLFKSFQVTGNRADLALAGDIVKEC--DAASRGLPRRFLTFICGRAGVCALGAVIAKH 176
Cdd:COG4403    51 TRAAAAGPAAADLYDGAAGIALFLAELARLTGDERYRELARAALRPLrrLLREELAGAMGPGLFTGLGGIAYALAHLGEL 130
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 177 CNDQLLLTH---YLSSFDEIIVTEKvPNELLYGRAGYLWACLFLNTHLGEktiphEHITSVAKDIID---EGRKLAKKGN 250
Cdd:COG4403   131 LGDPRLLEDalaLAALLEELIAADE-SLDVISGAAGAILALLALYRATGD-----PAALDLAIRCGDrllAAAVRDDGGR 204
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 251 CPLMYEWHGKKYWGAAHGLAGIMHVLMHTELKLDEK---DDVKNTLLYMIRNRYP-TGNYP--SSEGSESDRLVHWCHGA 324
Cdd:COG4403   205 AWPTPEPAGRPLTGFAHGAAGIAYALLRLAAATGDErylEAAREALAYERSLFDPeGGNWPdlREPDDGPRFRTAWCHGA 284
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 325 PGVALTLAKAYQVFHDEHFKQTAAEAAEVVWNRGLLKRVGICHGVSGNAYVFLSLYRLTGNVEYLYRAKAFACFLLEKAD 404
Cdd:COG4403   285 AGIGLARLALLRALGDPELREDLERALETTLRRGFGRNDSLCHGDAGNLELLLRAARATGDPELLEAARRLAALLLARAE 364
                         330       340       350
                  ....*....|....*....|....*....|....*...
gi 1002298665 405 Q---LIADGAMHGGDHPfSLFEGRAGMAYLLLDMVSPS 439
Cdd:COG4403   365 RagpLGLPGLPRGVESP-GLMTGLAGIGYGLLRLAAPE 401
LanM-like cd04792
Cyclases involved in the biosynthesis of class II lantibiotics, and similar proteins; ...
81-440 1.98e-23

Cyclases involved in the biosynthesis of class II lantibiotics, and similar proteins; LanM-like proteins. LanM is a bifunctional enzyme, involved in the synthesis of class II lantibiotics. It is responsible for both the dehydration and the cyclization of the precursor-peptide during lantibiotic synthesis. The C-terminal domain shows similarity to LanC, the cyclase component of the lan operon, but the N terminus seems to be unrelated to the dehydratase, LanB.


Pssm-ID: 271200 [Multi-domain]  Cd Length: 836  Bit Score: 103.55  E-value: 1.98e-23
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665  81 ERLLRAALR----IKDkVMEETWTRarrQVTDYTLYTGALGTALLLFKSFQVTGN--RADLALAGD--IVKECDAASRGL 152
Cdd:cd04792   462 LWLIRASLAnwigLDL-SDDGEWEL---SPLGADLYDGLSGIALFLAALAALTGDekYRDLARKALrpLRKLLRDLAADP 537
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 153 PRRFLTFICGRAGVCALGAVIAKHCNDQLLLTHYLSSFDEII--VTEKVPNELLYGRAGYLWACLFLNTHLGEKTIpHEH 230
Cdd:cd04792   538 RSLGIGGFTGLGSILYALSHLARLLGDPELLEDALELADLLTeaIIEDEELDIIGGSAGAILVLLALYERTGDERA-LEL 616
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 231 ITSVAKDIIdegrKLAKKGNCPLMYEW--HGKKYWGAAHGLAGIMHVLMHTELKLDEK---DDVKNTLLYmIRNRYPT-- 303
Cdd:cd04792   617 AIACGDHLL----KNAVENDGGARWKTpaSSRPLTGFAHGAAGIAWALLRLAAVTGDErylEAAKEALAY-ERSLFDPee 691
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 304 GNYPSSEGSESDRLVHWCHGAPGVALTLAKAYQVFHDEHFKQTAAEAAEVVWNRGLLKRVGICHGVSGNAYVFLSLYRLT 383
Cdd:cd04792   692 GNWPDRRKRNNSFSAAWCHGAAGIGLARLGLLKILNDDEIEEEIEKALETTLKYGFGNNDSLCHGDLGNLELLLVAAKLL 771
                         330       340       350       360       370       380
                  ....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 384 GNVEYLYRAKAFACFLLEKADQLIadGAMHG---GDHPFSLFEGRAGMAYLLLDMVSPSE 440
Cdd:cd04792   772 GDPELQEEAEELAAIVLNRAEEAG--GWLCGlptGVESPGLMTGLSGIGYGLLRLAAPDK 829
lanti_2_LanM TIGR03897
type 2 lantibiotic biosynthesis protein LanM; Members of this family are known generally as ...
83-433 1.71e-20

type 2 lantibiotic biosynthesis protein LanM; Members of this family are known generally as LanM, a multifunctional enzyme of lantibiotic biosynthesis. This catalysis by LanM distinguishes the type 2 lantibiotics, such as mersacidin, cinnamycin, and lichenicidin, from LanBC-produced type 1 lantibiotics such as nisin and subtilin. The N-terminal domain contains regions associated with Ser and Thr dehydration. The C-terminal region contains a pfam05147 domain, which catalyzes the formation of the lanthionine bridge. [Cellular processes, Toxin production and resistance]


Pssm-ID: 274840 [Multi-domain]  Cd Length: 931  Bit Score: 94.63  E-value: 1.71e-20
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665  83 LLRAALRIKDKVMEE---------TW---------TRARRQVTDYTLYTGALGTALLLFKSFQVTGNR--ADLALAGD-- 140
Cdd:TIGR03897 548 LLEEAKKIADRLLDNaiegddgsvNWiglnlsfdeERWSLGPLGNDLYDGLAGIALFLAYLAALTGDKryRDLARKALqp 627
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 141 IVKECDAASRGLPRRFLTFICGRAG-VCALgAVIAKHCNDQLLLTH---YLSSFDEIIVTEKVPNELLYGRAGYLWACLf 216
Cdd:TIGR03897 628 LRKYLETLVELARSMGLGAFSGLGSiIYAL-AHLGQLLNDPELLNDakkILNRLEELIIKDEEFLDLIGGAAGAILVLL- 705
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 217 lntHLGEKTiPHEHITSVAKDIideGRKLAKK-----GNCPLMYEWHGKKYWGAAHGLAGIMHVLmhteLKLDE------ 285
Cdd:TIGR03897 706 ---NLYEVT-GDPEVLELAIAC---GEHLLKQaveqeGGAAWKTSQSNKPLTGFSHGAAGIAWAL----LRLYKvtgdqr 774
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 286 -KDDVKNTLLYMiRNRYPT--GNYPSS-EGSESDRLVHWCHGAPGVALTLAKAYQVFHDEHFKQTAAEAAEVVWNRGLLK 361
Cdd:TIGR03897 775 yLEAAKEALAYE-RSLFDPeeGNWPDLrEDGGPQFPVAWCHGAPGILLSRLGLLEILDDDEIREDIEIALETTLKYGFGD 853
                         330       340       350       360       370       380       390
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1002298665 362 RVGICHGVSGNAYVFLSLYRLTGNVEYLYRAKAFACFLLEKADQ------LIADGAMHggdhpFSLFEGRAGMAYLLL 433
Cdd:TIGR03897 854 NDSLCHGDLGNLEILLEAAKVLDDEELQELARRIASQVLARLTKngryrlGLPRGVES-----PGLMTGLAGIGYGLL 926
LanC cd04793
Cyclases involved in the biosynthesis of lantibiotics; LanC is the cyclase enzyme of the ...
110-441 4.21e-16

Cyclases involved in the biosynthesis of lantibiotics; LanC is the cyclase enzyme of the lanthionine synthetase. Lanthinoine is a lantibiotic, a unique class of peptide antibiotics. They are ribosomally synthesized as precursor peptides and then post-translationally modified to contain thioether cross-links called lanthionines (Lans) or methyllanthionines (MeLans) in addition to 2,3-didehydroalanine (Dha) and (Z)-2,3-didehydrobutyrine (Dhb). These unusual amino acids are introduced by the dehydration of serine and threonine residues, followed by thioether formation via addition of cysteine thiols, catalysed by LanB and LanC or LanM. LanC, the cyclase component, is a zinc metalloprotein, whose bound metal has been proposed to activate the thiol substrate for nucleophilic addition. Also contains SpaC (the cyclase involved in the biosynthesis of subtilin), NisC, and homologs.


Pssm-ID: 271201  Cd Length: 377  Bit Score: 79.70  E-value: 4.21e-16
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 110 TLYTGALGTALLLFKSFQVTGNRADLALAGDIVkecDAASRGLPRRFLTF-ICGraGVCALGAVIAkHC-NDQLLLTHYL 187
Cdd:cd04793     1 SLSSGLPGIALLLSELARLTPDEGWDEKAHQYL---EAAIEELNSAGLSLsLFS--GLAGLAFALL-ALsRNGGRYQNLL 74
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 188 SSFDEIIV--TEKVPNE-------------LLYGRAG---YLWACLFLNTHLGEKTIphEHITSVAKDIIDEGRKLAKKG 249
Cdd:cd04793    75 SELNEYIDelAEDRLAEaiaregispgeydVISGLSGigrYLLERPPPADDLLEEIL--DYLVDLTEPIIEGGEKVPWPE 152
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 250 NCPLMYEwhgKKYW-------GAAHGLAGIMHVLMHTELKLDEKDDVKNTLL----YMIRNRYPtGNYPSSEGSESDRLV 318
Cdd:cd04793   153 LQPSESE---KKAYpsghfnlGLAHGIAGPLALLALALRRGIEVPGQREAIEriadWLLKWRQD-DDEGWWPTIVFPEEL 228
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 319 H------------WCHGAPGVALTLAKAYQVFHDEHFKQTAAEAAEVVWNR-GLLKRV---GICHGVSGNAYVFLSLYRL 382
Cdd:cd04793   229 SngrpppvpsrdaWCYGDPGIARALLLAGKALGDPELQELAEEALLAALRRpDELTGLispTLCHGYAGLLQIARRMYRD 308
                         330       340       350       360       370       380
                  ....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1002298665 383 TGNVEYLYRAKAFACFLLEKADQLIADGAMHGGDHPF-----SLFEGRAGMAYLLLDMVSPSES 441
Cdd:cd04793   309 TGEPALLAAAEELIDKLLDLYDPDLPFGFYDTGGSITplddpGLLEGAAGIALALLSAITDKEP 372
LanC_SerThrkinase cd04791
Lanthionine synthetase C-like domain associated with serine/threonine kinases; Some members of ...
263-435 5.64e-11

Lanthionine synthetase C-like domain associated with serine/threonine kinases; Some members of this subgroup lack the zinc binding site and the active site residues, and therefore are most likely inactive. The function of this domain is unknown.


Pssm-ID: 271199 [Multi-domain]  Cd Length: 327  Bit Score: 63.44  E-value: 5.64e-11
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 263 WGAAHGLAGIMHVLMHTELKLDEkdDVKNTLLYMIRNRYPTGN-------------YPSSEGSESDRLVHWC-------- 321
Cdd:cd04791     3 LNVAYGAAGVLLALHRAGGAVPE--ELEDWLVRRALRDLSLPPglydglagiawvlYELGRREEAERLLDRAlalpldsl 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 322 -----HGAPGVALTLAKAYQVFHDEHFKQTAAEAAE------------VVWNRGLLKRVGICHGVSGNAYVFLSLYRLTG 384
Cdd:cd04791    81 dpslySGLAGIGLALLHLARATGDPEFLERAARIAErlaarlreddpgVYWNDAGAVRAGLLHGWSGIALFLLRLYEATG 160
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|....*
gi 1002298665 385 NVEYLYRAKAFACFLLEKAdQLIADGAMHGGDHPFSLF----EGRAGMAYLLLDM 435
Cdd:cd04791   161 DPAYLDLAERALRKDLARC-VEDDDGALLQVDEGNRLLpylcSGSAGIGLVLLRY 214
LanC_SerThrkinase cd04791
Lanthionine synthetase C-like domain associated with serine/threonine kinases; Some members of ...
109-444 1.11e-09

Lanthionine synthetase C-like domain associated with serine/threonine kinases; Some members of this subgroup lack the zinc binding site and the active site residues, and therefore are most likely inactive. The function of this domain is unknown.


Pssm-ID: 271199 [Multi-domain]  Cd Length: 327  Bit Score: 59.59  E-value: 1.11e-09
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 109 YTLYTGALGTALLLFksfQVTGNRADLALagDIVKECDAASRGLPRRFLTficGRAGV----CALG-----AVIAKHCND 179
Cdd:cd04791     3 LNVAYGAAGVLLALH---RAGGAVPEELE--DWLVRRALRDLSLPPGLYD---GLAGIawvlYELGrreeaERLLDRALA 74
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 180 QLLLTHYLSsfdeiivtekvpneLLYGRAGYLWACLflntHLGEKTiPHEHITSVAKDIIDEGRKLAKKGNCPLMYEWHG 259
Cdd:cd04791    75 LPLDSLDPS--------------LYSGLAGIGLALL----HLARAT-GDPEFLERAARIAERLAARLREDDPGVYWNDAG 135
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 260 KKYWGAAHGLAGImhVLMHTELKLDEKDDV-----KNTLLYMIRNRYPTGNYPSSEGSESDRLV-HWCHGAPGVALTLAK 333
Cdd:cd04791   136 AVRAGLLHGWSGI--ALFLLRLYEATGDPAyldlaERALRKDLARCVEDDDGALLQVDEGNRLLpYLCSGSAGIGLVLLR 213
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 334 AYQVFHDEHFKQTAAEAAEVVwNRGLLKRVGICHGVSGNAYVFLSLYRLTGNVEYLYRAKAFA----CFLLEKADQLIAd 409
Cdd:cd04791   214 YLRHRGDDRYRELLEGIARAV-RSRFTVQPGLFHGLAGLGLALLDLAAALGDPRYRAAAERHArllnLHALPRDGGIAF- 291
                         330       340       350
                  ....*....|....*....|....*....|....*....
gi 1002298665 410 gamhGGDHPF----SLFEGRAGMAYLLLDMVSPSESKFP 444
Cdd:cd04791   292 ----PGDQLLrlstDLATGSAGVLLALLRLLHGGRSWLP 326
YyaL COG1331
Uncharacterized conserved protein YyaL, SSP411 family, contains thoiredoxin and six-hairpin ...
331-414 1.24e-06

Uncharacterized conserved protein YyaL, SSP411 family, contains thoiredoxin and six-hairpin glycosidase-like domains [General function prediction only];


Pssm-ID: 440942 [Multi-domain]  Cd Length: 672  Bit Score: 51.00  E-value: 1.24e-06
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002298665 331 LAKAYQVFHDEHFKQTAAEAAEVVWNR-----GLLKRVgICHGVSGN-------AYV---FLSLYRLTGNVEYLYRAKAf 395
Cdd:COG1331   422 LAEAGRVLGDPEYLEAAERAADFILDNlwdpdGRLLRS-YRDGEAGIpgfledyAFLieaLLALYEATGDPRWLERALE- 499
                          90
                  ....*....|....*....
gi 1002298665 396 acfLLEKADQLIADGAMHG 414
Cdd:COG1331   500 ---LADEALEHFWDPEDGG 515
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH